Emergent BioSolutions (NSYE:EBS) announced today that it plans to put its over-the-counter Narcan nasal spray on U.S. shelves next month.
FDA approved the over-the-counter Narcan spray in May. Approval enabled direct-to-consumer sales in places like drug stores, convenience stores and more. The FDA nod came about six weeks after an agency committee voted unanimously in favor of OTC use. It marked the first approval for a naloxone product for use without a prescription.
The naloxone HCl nasal spray (4 mg) will become available on shelves nationwide and online beginning in September.
Get the full story at our sister site, Drug Delivery Business News.